Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Radiology

Background:

• Atherosclerosis progression is common, but regression is sporadically observed in humans.
• Hyperlipoproteinemia significantly increases atherosclerosis risk.
• Early detection and intervention are crucial for managing cardiovascular disease.

Purpose of the Study:

• To evaluate changes in early atherosclerosis in patients with hyperlipoproteinemia.
• To determine the impact of lipid and blood pressure management on atherosclerotic lesion progression or regression.
• To explore factors contributing to observed atherosclerosis regression.

Main Methods:

• Femoral angiograms were used to assess atherosclerotic changes in patients with Type II and Type IV hyperlipoproteinemia.
• Patients received drug and diet therapy to manage elevated blood lipids and blood pressure.
• Repeat angiograms were performed after 13 months to compare lesion status.

Main Results:

• Atherosclerosis regression was observed in 9 out of 25 patients.
• Patients with lesion improvement showed significant reductions in serum cholesterol, triglycerides, and blood pressure.
• No significant lipid or blood pressure changes were noted in patients with lesion progression.

Conclusions:

• Early atherosclerosis regression is achievable in select hyperlipoproteinemia patients with aggressive lipid and blood pressure management.
• The study's findings suggest that patient selection and sensitive radiographic methods are key to observing regression.
• This research highlights the potential for reversing early arterial disease, contrasting with the typical progression observed in other studies.